performance of the Company three-month for the Quarter 1/2020 ended 31 March 2020 are as follows: change Q1/2020 Q1/2019 increase (decrease) Sales 224.5 213.9 5.0% Other income 1.9 10.8 -82.3% Cost of sales

second quarter ended June 30, 2020 which the details are as follows: Unit: million Baht For 3-month period (Apr-Jun) 2020 2019 Change % Increase (Decrease) Revenue from sale of goods 128.52 164.02 (35.50

months ended 30th June 2019 Change THB million % THB million % THB million % Sales of electricity 175.94 100.00 85.70 100.00 90.25 105.31 Cost of goods sold (77.17) -43.86 (36.95) -43.12 (40.22) 108.84

10.73% 30 September 2020 31 December 2019 Change DOD BIOTECH PUBLIC COMPANY LIMITED เลขที่ 111 หมู่ที่ 2 ตาํบลท่าจนี อาํเภอเมืองสมุทรสาคร จงัหวดัสมุทรสาคร 74000 111 Moo 2 TambonThachin

and its subsidiary for the third quarter ended September 30, 2019 which the details are as follows: Unit: million Baht For 3-month period (July-Sep) 2019 2018 Change % Increase (Decrease) Revenue from

difference in the procedures to the extent that it will not materially change the work system and personnel provided in the application; (2) the rules and regulations of the derivatives exchange necessary for

mainly from the recognition of billboard structure of THB 147mn, an increase in work in process of LED screens installation of THB 127mn and the recognition of COMASS’s assets after consolidation of THB

’ Equity As at 30 September 2017, the total shareholder’s Equity of the Company were 5,902 Million Baht, mainly due to the recognition value of joint venture of the Apollo’s deal and realized gain from the

, Pathumwan, Bangkok 10330 Tel. 66 2 654 3344 Fax. 66 2 654 3323 As at 30 September 2017, the total shareholder’s Equity of the Company were 4,506 Million Baht, mainly due to the recognition value of joint

to obtain a customer contract shall be recorded as an asset and amortized to expenses on a basis that is consistent with the pattern of revenue recognition. Under the previous accounting policy, the